KENNEWICK, Wash., March 4, 2008 — Advanced Medical Isotope Corporation (AMIC) reports that it took delivery on Monday of the first compact linear accelerator in North America designed specifically for the production of medical isotopes used in Positron Emission Tomography (PET) imaging, as well as many other important diagnostic and therapeutic medical isotopes. This PULSAR (r) Isotope Production system, which sets a new standard for production of PET and other isotopes using proton beams, is a more compact and reliable alternative to cyclotrons, incorporating proven compact accelerator technology integrated with high production yield targets and advanced chemistry process units.
Production will commence within the next several weeks at the Kennewick production facility, with plans for additional production facilities scheduled in the coming months.
“Our goal is to empower physicians, medical researchers, and biotechnology companies by providing them with essential medical isotopes that heretofore have not been feasible or economical, in an effort to detect and cure human disease,” stated William J. Stokes, CEO of AMIC. “With this compact linear accelerator, the first of its kind in North America designed specifically for the production of PET isotopes such as Fluorine-18, Nitrogen-13, Carbon-11, and Oxygen-15, our team will also be able to produce other highly desired longer lived isotopes including Actinium-225, Iodine-123 and Indium-111 for diagnostic as well as therapeutic applications.”
Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advanced systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotope Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.isotopia.us
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company’s ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely developments and acceptance of new products, the impact of competitive products and pricing, the timely developments and release of products by suppliers, and other risks.
Advanced Medical Isotope Corporation
James C. Katzaroff
Fax: (509) 736-4000
Source: Advanced Medical Isotope Corporation